Hospices will soon participate in pilot testing a draft version of an item set that covers the comprehensive patient assessment.
CMS’ inaugural release of Hospice Compare uncovers several opportunities for hospices to stand apart from competition. Among them: Ensuring patients treated with an opioid are given a bowel regimen.
Medicare’s hospice payments, adjusted for inflation and other factors, will rise an estimated 1% in 2018, according to the final hospice payment rule posted Aug. 1.
Hospices may soon have a less taxing way to return overpayments to CMS, officials from the federal Medicare agency announced during a July 20 home health, hospice and durable medical equipment (DME) open door forum.
In comments about the proposed 2018 hospice rule, industry stakeholders expressed major concerns about CMS’ future plans to change hospice eligibility requirements.
Due to system errors as a result of the new hospice payment structure, CMS is asking all hospices to take it upon themselves to identify claims in which they were overpaid since January 2016 — and pay the federal Medicare agency back.
Now that Alzheimer’s disease has risen to become by far the most commonly used hospice claims-reported diagnosis, hospices must be even more certain that their documentation for Alzheimer’s patients can withstand auditor scrutiny.
A newly announced probe involving routine home care services is yet another example of how auditors have begun targeting hospices in recent years due to perceived issues with documentation and medical necessity.
CMS on June 1 will provide hospices preview reports in advance of Hospice Compare’s launch. This will be hospices’ first chance to see how they’ll stack up against the nation when Hospice Compare appears this summer.
It might seem like cause for long-term concern when you see hospices only are expected to receive a 1% payment increase in 2018 — compared to a 2.1% increase in 2017.


User Name: